Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR)

Shanghai Biotecan Pharmaceuticals Co.,Ltd.
A leading enterprise in precision medicine

Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR)

Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person, which is caused by a novel coronavirus (SARS-CoV-2). SARS-CoV-2 Detection Kit is a fast and sensitive real-time RT-PCR assay, which combines reverse transcription and PCR amplification in one-step procedure.

  1. Comprehensive
    One test for two targets(ORF1ab and N gene)
  2. High Sensitivity
    300 copies/mL
  3. Rapid
    1.5 hours for amplification and results interpretation
  4. Compatibility
    Adaptive to most PCR equipments
  5. Specimens
    Nasopharyngeal or oropharyngeal swabs, sputum and broncheoalveolar lavage

Work flow

1. Sample Collection

2. Automatic Nucleotide Extraction

3. PCR Amplification

Product Information

Catalogue NO. Product Name Model User Manual Performance Evaluation Data
BT2020-002 Novel Coronavirus 2019-nCoV Nucleic Acid Detection Kit (Real Time PCR) 50T

* Tests have been validated but FDA's independent review of this validation is pending.


About us
At Shanghai Biotecan Pharmaceuticals Co.,Ltd., our mission is to provide the best healthcare services and products through the most advanced technology. The company’s goal is to empower every medical professional and patient with systematic precision medicine solutions. Biotecan uses strict quality management control system and strictly follows China’s GLP & GMP standards. The company has over 60 clinical molecular diagnostic laboratories across China and two affiliated GMP facilities located in Shanghai and currently provides over 2000 different types of clinical testing services and 11 medical devices and diagnostic reagents.

Shanghai Biotecan Pharmaceuticals Co.,Ltd.
Address:First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China